Beltrán Arranz A, Berninger B (2023)
Seizing hope: Advancing cell therapy for pharmaco-resistant epilepsy toward the clinic.Cell Stem Cell 30: 1287-1289.
In this issue of Cell Stem Cell, Bershteyn et al.1 developed a human interneuron cell therapy that reduced spontaneous seizure activity in a mouse model of mesial temporal lobe epilepsy (MTLE). The data presented here support an ongoing phase 1/2 clinical trial for the treatment of pharmaco-resistant epilepsy in patients.
